U.S. Markets open in 4 hrs 10 mins
  • S&P Futures

    4,314.25
    -3.50 (-0.08%)
     
  • Dow Futures

    33,970.00
    -73.00 (-0.21%)
     
  • Nasdaq Futures

    14,043.75
    +57.00 (+0.41%)
     
  • Russell 2000 Futures

    1,912.50
    -15.80 (-0.82%)
     
  • Crude Oil

    86.94
    +0.33 (+0.38%)
     
  • Gold

    1,791.80
    -3.20 (-0.18%)
     
  • Silver

    22.54
    -0.14 (-0.60%)
     
  • EUR/USD

    1.1137
    -0.0010 (-0.0891%)
     
  • 10-Yr Bond

    1.8070
    0.0000 (0.00%)
     
  • Vix

    30.69
    -1.27 (-3.97%)
     
  • GBP/USD

    1.3375
    -0.0006 (-0.0468%)
     
  • USD/JPY

    115.6170
    +0.3150 (+0.2732%)
     
  • BTC-USD

    36,524.12
    -93.56 (-0.26%)
     
  • CMC Crypto 200

    827.54
    +8.04 (+0.98%)
     
  • FTSE 100

    7,475.12
    -79.19 (-1.05%)
     
  • Nikkei 225

    26,717.34
    +547.04 (+2.09%)
     

Did Psychemedics Corporation (NASDAQ:PMD) Insiders Buy Up More Shares?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • PMD

We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we'll take a look at whether insiders have been buying or selling shares in Psychemedics Corporation (NASDAQ:PMD).

Do Insider Transactions Matter?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require that the company discloses such transactions to the market.

Insider transactions are not the most important thing when it comes to long-term investing. But it is perfectly logical to keep tabs on what insiders are doing. For example, a Harvard University study found that 'insider purchases earn abnormal returns of more than 6% per year'.

See our latest analysis for Psychemedics

The Last 12 Months Of Insider Transactions At Psychemedics

In the last twelve months, the biggest single purchase by an insider was when insider Peter Kamin bought US$258k worth of shares at a price of US$4.68 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$6.96. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

In the last twelve months Psychemedics insiders were buying shares, but not selling. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
insider-trading-volume

Psychemedics is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership of Psychemedics

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 14% of Psychemedics shares, worth about US$5.3m, according to our data. Whilst better than nothing, we're not overly impressed by these holdings.

So What Do The Psychemedics Insider Transactions Indicate?

There haven't been any insider transactions in the last three months -- that doesn't mean much. But insiders have shown more of an appetite for the stock, over the last year. While we have no worries about the insider transactions, we'd be more comfortable if they owned more Psychemedics stock. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To that end, you should learn about the 2 warning signs we've spotted with Psychemedics (including 1 which is significant).

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.